Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Therapies to TMJ Arthrocentesis in TMJ Disorders
NCT07479693Completed
- Sponsor
- Ondokuz Mayıs University
- Start
- Jan 2025
- Primary completion
- Aug 2025
- Modality
- Polymer-based Nanoparticles, Device-based Delivery, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of hyaluronic acid, injectable platelet-rich fibrin and dextrose in temporomandibular joint disorder (TMJ) (4 arms), sponsored by Ondokuz Mayıs University. Primary endpoints: Change in Pain Intensity at 3 months and Change in Maximum Mouth Opening at 3 months. Started Jan 2025; status: completed.
02
Drugs
hyaluronic acidinjectable platelet-rich fibrindextrose
03
Conditions
temporomandibular joint disorder (TMJ)
Beyond the preview
Go deeper on NCT07479693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07479693.